Atjaunināt sīkdatņu piekrišanu

E-grāmata: Reactive Oxygen Species: Network Pharmacology and Therapeutic Applications

Edited by , Edited by , Edited by
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 213,54 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Reactive Oxygen Species: Network Pharmacology and Therapeutic ApplicationsPalielināt
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants. This book is a game changer for the field and many clinical areas such as cardiology and neurology. The term ‘oxidative stress’ is abandoned and replaced with a systems medicine and network pharmacology-based mechanistic approach to disease. The ROS-related drugs discussed here target either ROS- forming or ROS -modifying enzymes for which there is strong clinical evidence. In addition, ROS targets are included as they jointly participate in causal mechanisms of disease. This approach is transforming the ROS field and represents a breakthrough in redox medicine indicating a path to patient benefit. In the coming years more targets and drugs may be discovered, but the approach will remain the same and this book will thus become, and for many years remain, the leading reference for ROSopathies and their treatment by network pharmacology.  

Chapter "Soluble Guanylate Cyclase Stimulators and Activators" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.  


Part I: ROS Revisited: Changing the Focus from Oxidative Stress and
Redox Biology to Redox Medicine.- Demystifying oxidative stress.- Oxidants in
Physiological Processes.- Network Medicine-Based Unbiased Disease Modules for
Drug and Diagnostic Target Identification in ROSopathies.- Part II Targeting
antioxidant responses.- Development of Telintra as an Inhibitor of
Glutathione S-Transferase P.- Perspectives on the Clinical Development of
NRF2-Targeting Drugs.- Part III: Inhibiting ROS formation and toxification.-
NOX Inhibitors: From Bench to Naxibs to Bedside.- Nitric Oxide Synthase
Inhibitors into the Clinic at Last.- Xanthine Oxidoreductase Inhibitors.-
Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.-
Inhibition of Myeloperoxidase.- Part IV: Stimulating/substituting ROS.-
Effects of Mammalian Thioredoxin Reductase Inhibitors.- Cardiovascular
Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO) and Nitroxyl
(HNO), in the Setting of Reactive Oxygen Species Dysregulation.-
Tetrahydrobiopterin and Nitric Oxide Synthase Recouplers.- Part V: Repairing
ROS damage.- Soluble Guanylate Cyclase Stimulators and Activators Peter
Sander.- Inhibitors of Advanced Glycation End Product (AGE) Formation and
Accumulation.
Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97830306851026e.html
Keywords: